General Clinical Considerations

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Hereditary Hemochromatosis. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hereditary Hemochromatosis (online CE course)
General Clinical Considerations

HH is frequently discovered only during management of associated illness or routine health evaluations. It has been estimated that only a small percentage of all affected persons are actually diagnosed. Individuals with HH may be symptomatic for several years prior to diagnosis and may have consulted multiple health care providers.
Under-diagnosis of HH is thought to occur due to:
• Lack of specificity of early signs and symptoms
• Asymptomatic status of some patients until damage to organs and tissues has occurred
• Confusion with liver disease due to other causes
• Insufficient awareness and knowledge of HH

Early identification of persons with HH is essential to prevent serious and irreversible complications associated with severe iron overload. A classic triad of skin hyperpigmentation (bronzing), type 2 diabetes, and hepatic cirrhosis has long been recognized as evidence of advanced iron overload. However, persons with HH may present with a much wider variety of signs and symptoms, particularly if they are seen before significant iron accumulation has occurred.
Age of presentation and disease severity are highly variable.